Skip to main content
Clinical Trials/NCT01453842
NCT01453842CompletedPhase 1

Diet Oil Induced Stimulation of GLP-1

University of Copenhagen1 site in 1 country12 target enrollmentStarted: March 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
12
Locations
1
Primary Endpoint
Plasma GLP-1

Study Overview

Brief Summary

Activation of G protein-coupled receptor GPR119 stimulates glucagon-like peptide-1 (GLP-1)release from the intestinal L-cells. Previously, administration of 2-oleyl-glycerol (2-OG) to humans significantly increased plasma GLP-1. In the present study we want to test the effect in patients with type 2 diabetes. The hypothesis is that we will expect to find a significant increased plasma GLP-1 following a meal containing of 2-OG when compared to meals containing of olive oil or carbohydrates alone.

Detailed Description

Activation of G protein-coupled receptor GPR119 stimulates glucagon-like peptide-1 (GLP-1)release from the intestinal L-cells. Previously, administration of 2-oleyl-glycerol (2-OG) to humans significantly increased plasma GLP-1. In the present study we want to test the effect in patients with type 2 diabetes. The hypothesis is that we will expect to find a significant increased plasma GLP-1 following a meal containing of 2-OG when compared to meals containing of olive oil or carbohydrates alone. The aim of the study is to elucidate the effect of 2-OG, 'diet oil' on GLP-1 secretion in patients with type 2 diabetes and to explain the mechanism behind the known stimulation of GLP-1 release by dietary fat.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with type 2 diabetes mellitus according to the WHO criteria
  • •caucasians
  • •age above 18 years
  • •BMI 20-30

Exclusion Criteria

  • •kidney disease
  • •liver disease
  • •retinopathy
  • •use of insulin
  • •use of GLP-1 analogues
  • •use of DPP-4 inhibitors

Arms & Interventions

Diet oil

Experimental

Intervention: Diet oil (Dietary Supplement)

Carrot

Placebo Comparator

Intervention: Carrot (Dietary Supplement)

Olive oil

Active Comparator

Intervention: Olive oil (Dietary Supplement)

Outcomes

Primary Outcomes

Plasma GLP-1

Time Frame: 3 hours

Glp-1 response is measured during and three hours after ingestion of the different mealtest

Secondary Outcomes

  • Plasma insulin(3 hours)
  • Plasma glucose(3 hours)
  • Plasma GIP(3 hours)
  • Plasma glucagon(3 hours)
  • Plasma PYY(3 hours)
  • Plasma paracetamol(3 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Katrine Bagge Hansen

MD

University of Copenhagen

Study Sites (1)

Loading locations...

Similar Trials